Lyme Disease - Pipeline Review, H1 2016

Publisher Name :
Date: 24-Feb-2016
No. of pages: 33
Inquire Before Buying

Global Markets Direct's, ‘Lyme Disease - Pipeline Review, H1 2016', provides an overview of the Lyme Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Lyme Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Lyme Disease and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Lyme Disease

  • The report reviews pipeline therapeutics for Lyme Disease by companies and universities/research institutes based on information derived from company and industry-specific sources

  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved Lyme Disease therapeutics and enlists all their major and minor projects

  • The report assesses Lyme Disease therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

  • The report summarizes all the dormant and discontinued pipeline projects

  • The report reviews latest news related to pipeline therapeutics for Lyme Disease

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Identify and understand important and diverse types of therapeutics under development for Lyme Disease

  • Identify potential new clients or partners in the target demographic

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

  • Devise corrective measures for pipeline projects by understanding Lyme Disease pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Lyme Disease - Pipeline Review, H1 2016

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Lyme Disease Overview 6
Therapeutics Development 7
Pipeline Products for Lyme Disease - Overview 7
Lyme Disease - Therapeutics under Development by Companies 8
Lyme Disease - Pipeline Products Glance 9
Late Stage Products 9
Clinical Stage Products 10
Early Stage Products 11
Lyme Disease - Products under Development by Companies 12
Lyme Disease - Companies Involved in Therapeutics Development 13
LondonPharma Ltd 13
Valneva SE 14
Lyme Disease - Therapeutics Assessment 15
Assessment by Monotherapy Products 15
Assessment by Target 16
Assessment by Mechanism of Action 18
Assessment by Route of Administration 20
Assessment by Molecule Type 22
Drug Profiles 24
azithromycin - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Lyme disease vaccine 2 - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Nu-3 - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Small Molecule for Lyme Disease - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
VLA-15 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Lyme Disease - Recent Pipeline Updates 30
Lyme Disease - Dormant Projects 31
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 32
Disclaimer 33

List of Tables

Number of Products under Development for Lyme Disease, H1 2016 7
Number of Products under Development by Companies, H1 2016 8
Comparative Analysis by Late Stage Development, H1 2016 9
Comparative Analysis by Clinical Stage Development, H1 2016 10
Comparative Analysis by Early Stage Development, H1 2016 11
Products under Development by Companies, H1 2016 12
Lyme Disease - Pipeline by LondonPharma Ltd, H1 2016 13
Lyme Disease - Pipeline by Valneva SE, H1 2016 14
Assessment by Monotherapy Products, H1 2016 15
Number of Products by Stage and Target, H1 2016 17
Number of Products by Stage and Mechanism of Action, H1 2016 19
Number of Products by Stage and Route of Administration, H1 2016 21
Number of Products by Stage and Molecule Type, H1 2016 23
Lyme Disease Therapeutics - Recent Pipeline Updates, H1 2016 30
Lyme Disease - Dormant Projects, H1 2016 31

List of Figures

Number of Products under Development for Lyme Disease, H1 2016 7
Number of Products under Development by Companies, H1 2016 8
Comparative Analysis by Early Stage Products, H1 2016 11
Assessment by Monotherapy Products, H1 2016 15
Number of Products by Targets, H1 2016 16
Number of Products by Stage and Targets, H1 2016 16
Number of Products by Mechanism of Actions, H1 2016 18
Number of Products by Stage and Mechanism of Actions, H1 2016 18
Number of Products by Routes of Administration, H1 2016 20
Number of Products by Stage and Routes of Administration, H1 2016 20
Number of Products by Molecule Types, H1 2016 22
Number of Products by Stage and Molecule Types, H1 2016 22
  • Global Ampicillin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 07-Jan-2020        Price: US 3480 Onwards        Pages: 103
    Summary Market Overview The global Ampicillin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 177.8 million by 2025, from USD 161.2 million in 2019. The Ampicillin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales an......
  • Global Metronidazole Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 116
    Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc. The metronidazole industry concentration is not high. In the world wide, China has a long history and unshakable status in this industry and......
  • Global Cephalosporin Market Research Report 2020
    Published: 02-Jan-2020        Price: US 2900 Onwards        Pages: 135
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation in 2016 is about 37.2%, and the proportion is in increasing trend from 2012 to 2016. The global Cephalosporin market is valued at 3835.6 million US$ in 2020 is expected to reach 4382.3 million US$ by the end of ......
  • Global Metronidazole Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 02-Jan-2020        Price: US 3480 Onwards        Pages: 138
    Summary Market Overview The global Metronidazole market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -0.5% in the forecast period of 2020 to 2025 and will expected to reach USD 115.6 million by 2025, from USD 117.9 million in 2019. The Metronidazole market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, s......
  • Global Clotrimazole Market Research Report 2020
    Published: 01-Jan-2020        Price: US 2900 Onwards        Pages: 122
    Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad......
  • Global Cephalosporin Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
    Published: 31-Dec-2019        Price: US 3350 Onwards        Pages: 128
    Summary The global Cephalosporin market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2019 and 2025. This report studies the Cephalosporin market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, ri......
  • Global Antibiotics Market Data Survey Report 2015-2025
    Published: 30-Dec-2019        Price: US 1500 Onwards        Pages: 66
    Summary The global Antibiotics market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, sales d......
  • Global Aspergillosis Drugs Market Data Survey Report 2015-2025
    Published: 30-Dec-2019        Price: US 1500 Onwards        Pages: 67
    Summary The global Aspergillosis Drugs market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile,......
  • Global Ampicillin Market Data Survey Report 2015-2025
    Published: 29-Dec-2019        Price: US 1500 Onwards        Pages: 63
    Summary The global Ampicillin market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, sales da......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs